Bioequivalence of Two Tablet Forms of MK0974 (0974-045)

An Open-Label, Randomized, 2-Period Crossover Study to Evaluate the Bioequivalence of a Single Dose of a Tablet Form of MK0974 Ethanolate vs. a Single Dose of a Tablet Form of MK0974 Hydrate in Healthy Subjects

This study will evaluate the bioequivalence of two solid dose formulations of MK0974.

Inclusion Criteria:

• Subject is in good health
• Subject is a non-smoker
• Subject is willing to comply with the study restrictions

Exclusion Criteria:

• Subject has a history of stroke, chronic seizures, or major neurological disorder
• Subject has a history of cancer
• Subject is a nursing mother
• Subject has or has a history of any disease or condition that might make participation in the study unsafe or that might confound the results of the study